Peptide library › Longevity & cellular health
Elamipretide
Also known as SS-31, Forzinity, Bendavia
Mitochondria-targeting peptide approved for the rare genetic disorder Barth syndrome.
What people use it for
- Barth syndrome (approved use)
- Mitochondrial disease and heart failure (research)
- Healthy ageing and energy (popular use)
What Elamipretide does in the body
A small peptide that travels to the inner membrane of mitochondria, the cell's power plants, and binds cardiolipin, a fat that holds the energy-producing machinery together. This is thought to stabilise that machinery, improve energy production and reduce oxidative stress.
Strength of evidence
Moderate for Barth syndrome (approved on surrogate endpoints); mixed results in other mitochondrial and heart conditions.
Look up the evidence
- Reviews on PubMed: Summaries of the published research
- Clinical trials on PubMed: Published studies in people
- ClinicalTrials.gov: Registered trials, past and ongoing
- Prescribing information (DailyMed, US): Official US label
- Patient leaflets (emc, UK): Official UK product information
Live searches of official databases. New to the terms? See the glossary.
Reported side effects & risks
- Injection-site reactions (very common)
- Headache
- Dizziness
Who should avoid it or take extra care
- Pregnant or breastfeeding (limited data)
- Anyone without the approved condition (Barth syndrome) outside a trial
Not a complete list. Check with a doctor or pharmacist about your own health and medicines.
Regulatory status
FDA-approved (accelerated approval) as Forzinity for Barth syndrome. Other uses are not approved.
How it's taken
Route: Injection under the skin once daily
How long it lasts (half-life): A few hours
Latest research & news
- An Intermediate Size Expanded Access Protocol of Elamipretide
Clinical trial · Available · Updated · ClinicalTrials.gov · 16 Oct 2026 - Mitochondrial Quality Control in Degenerative Musculoskeletal Diseases: Signaling Networks and Therapeutic Landscapes
Research · Review · PubMed · Adv Sci (Weinh) · 14 Oct 2026 - Elamipretide Rejuvenates Oocyte Quality and Restores Female Fertility During Reproductive Aging
Research · Study · PubMed · Aging Cell · 1 Oct 2026 - Mitochondrial Quality Control in Inherited Mitochondrial Cardiomyopathy: Convergent Pathobiology and a Testable Therapeutic Framework
Research · Review · PubMed · Int J Mol Sci · 17 Sept 2026 - Clinical Trial in Patients With Barth Syndrome- 4TAZPower
Clinical trial · Recruiting · Phase 4 · Updated · ClinicalTrials.gov · 17 Sept 2026
Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.
Keep track of Elamipretide privately
Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.
Open Elamipretide in Fiala How to installMore in Longevity & cellular health
- EpitalonSynthetic four-amino-acid peptide researched for anti-aging effects.
- MOTS-cMitochondria-derived peptide studied for metabolism and exercise capacity.
- HumaninSmall peptide made by mitochondria, studied in the lab for protecting cells from age-related damage.
- FOXO4-DRIExperimental 'senolytic' peptide that cleared ageing cells in mice.
- GlutathioneThe body's main antioxidant, a tripeptide sold as a supplement and given by injection for skin lightening.